Hungary Pharmaceuticals and Healthcare Sector Report 2016/2017

  • ID: 4313138
  • Report
  • Region: Hungary
  • 69 pages
  • EMIS, A Euromoney Institutional Investor Company
1 of 5
The Hungarian Production Of Pharmaceuticals Is Export-Oriented - Foreign Markets Account For 84.5% Of The Manufacturers’ Turnover.

FEATURED COMPANIES

  • Egis
  • Gedeon Richter
  • Synlab Hungary
  • Teva
  • MORE
This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Hungary. We present in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

Understand the key elements at play in the healthcare and pharmaceutical sector in Hungary
Access forecasts for growth in the sector
View key data on healthcare spending and health insurance in Hungary
Crystallise the forces both driving and restraining this sector in Hungary
Build a complete perspective on sector trade, investment and employment
Understand the competitive landscape and who the major players are
View M&A activity and major deals
Gain an understanding of the regulatory environment for the sector in Hungary
Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels)
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Egis
  • Gedeon Richter
  • Synlab Hungary
  • Teva
  • MORE
01 EXECUTIVE SUMMARY
Sector in Numbers 2015
Sector Overview
Sector Snapshot
Healthcare Sector Outlook
Pharmaceutical Sector Outlook
Driving Forces
Restraining Forces
02 SECTOR IN FOCUS
Main Economic Indicators
Main Sector Indicators
Regional Positioning
Health Tourism
Investment
Employment and Wages
03 COMPETITIVE LANDSCAPE
Highlights
Top Companies - Healthcare
Market Shares – Pharmaceuticals
Top Companies – Pharmaceuticals
M&A Deals
M&A Activity
04 COMPANIES IN FOCUS
FMC Dializis Center Egeszsegugyi
Synlab Hungary
Gedeon Richter
Teva
Egis
05 REGULATORY ENVIRONMENT
Regulatory Bodies
Government Policy
06 PHARMACEUTICALS
Highlights
Production
Manufacturers
Sales
OTC Medicines
Prescription Drugs
Social Insurance Subsidies
External Trade
Exports
Imports
07 HEALTHCARE
Highlights
Healthcare Expenditure
National Health Insurance Fund
Voluntary Health Funds
Personnel
Focus Point - Number of Physicians in Active
Service per 10,000 Inhabitants
Hospitals
Focus Point - Number of Hospital Beds in Use
per 10,000 Inhabitants
Healthcare Utilisation
Demographic Trends
Population Health
Disease Trends and Risk Factors
08 RETAIL CHANNELS
Retail
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Egis
  • Gedeon Richter
  • Synlab Hungary
  • Teva
  • MORE
In 2015, the total Hungarian healthcare expenditure amounted to HUF 2,373.4bn, or 7.04% of GDP. Public financing schemes made up 67.1% of the healthcare spending. By regional standards, the Hungarian health spending as a percentage of GDP is high, but significantly lower than that of the Western European countries. The total value of the pharmaceutical market was HUF 660.8bn in 2015, while the value of the pharmaceutical output was HUF 816.5bn. According to EFPIA, only Poland produces more medicines in the region. The Hungarian production is export-oriented - foreign markets account for 84.5% of the manufacturers’ turnover. At the end of 2015, the number of employees in the healthcare sector was 262,100 or 6.2% of the total workforce, while pharmaceutical manufacturing companies employed 24,900 people.
Note: Product cover images may vary from those shown
5 of 5
FMC Dializis Center Egeszsegugyi
Synlab Hungary
Gedeon Richter
Teva
Egis
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll